Mayo Clinic researchers document safer treatment for atrial fibrillation

September 27, 2002

Mayo Clinic researchers report that the risk of stroke that sometimes results from a common treatment for atrial fibrillation can be minimized when the patient takes anticoagulation medication prior to the procedure.

The researchers report on the largest single medical center experience regarding safety of elective direct current (DC) cardioversion of atrial fibrillation. DC cardioversion is the electronic restoration of the heart's normal rhythm.

Atrial fibrillation affects more than 2.5 million people in the United States. It is characterized by an irregular and rapid beating of the heart's atrial chambers and results when the normal electrical conduction system of the atria is not functioning properly. It is estimated that atrial fibrillation is responsible for more than 70,000 strokes each year in the United States. The prevalence of atrial fibrillation increases with age.

The researchers found that the rate of stroke or other embolic happenings -- clots or blockages of the blood vessels -- occurring in a patient after cardioversion was less than 1 percent. In the study, 834 successful cardioversions were performed in 717 patients from 1990 through 1994. Researchers said that use of adequate anticoagulation medication prior to the procedure reduced the risk of thromboembolism.

Mayo Clinic researchers involved in the study were Federico Gentile, M.D.; Bijoy Khanderia, M.D.; James Seward, M.D.; Christine Lohse, BSc; Win-Kuang Shen, M.D.; Kent Bailey, Ph.D.; Samantha Montgomery, MSc; Belli Burger, BSc and A. Jamil Tajik, M.D. Abdou Elhendy, M.D., Ph.D. is now with the University of Nebraska, Omaha.

Warren Manning, M.D., and Peter Zimetbaum, M.D., of Beth Israel Deaconess Medical Center in Boston, write in an accompanying editorial that clinicians must assess the individual patient to determine the benefits of cardioversion.

"If the decision favors cardioversion, (the researchers) have provided further proof of the efficacy of three to four weeks of warfarin anticoagulation before cardioversion," the editorialists write about the current approach to treatment.
-end-
Additional contact information:
John Murphy
507-284-5005 (days)
507-284-2511 (evenings)
e-mail: newsbureau@mayo.edu


Mayo Clinic

Related Stroke Articles from Brightsurf:

Stroke alarm clock may streamline and accelerate time-sensitive acute stroke care
An interactive, digital alarm clock may speed emergency stroke care, starting at hospital arrival and through each step of the time-sensitive treatment process.

Stroke patients with COVID-19 have increased inflammation, stroke severity and death
Stroke patients who also have COVID-19 showed increased systemic inflammation, a more serious stroke severity and a much higher rate of death, compared to stroke patients who did not have COVID-19, according a retrospective, observational, cross-sectional study of 60 ischemic stroke patients admitted to UAB Hospital between late March and early May 2020.

'Time is vision' after a stroke
University of Rochester researchers studied stroke patients who experienced vision loss and found that the patients retained some visual abilities immediately after the stroke but these abilities diminished gradually and eventually disappeared permanently after approximately six months.

More stroke awareness, better eating habits may help reduce stroke risk for young adult African-Americans
Young African-Americans are experiencing higher rates of stroke because of health conditions such as high blood pressure, diabetes and obesity, yet their perception of their stroke risk is low.

How to help patients recover after a stroke
The existing approach to brain stimulation for rehabilitation after a stroke does not take into account the diversity of lesions and the individual characteristics of patients' brains.

Kids with headache after stroke might be at risk for another stroke
A new study has found a high incidence of headaches in pediatric stroke survivors and identified a possible association between post-stroke headache and stroke recurrence.

High stroke impact in low- and middle-income countries examined at 11th World Stroke Congress
Less wealthy countries struggle to meet greater need with far fewer resources.

Marijuana use might lead to higher risk of stroke, World Stroke Congress to be told
A five-year study of hospital statistics from the United States shows that the incidence of stroke has risen steadily among marijuana users even though the overall rate of stroke remained constant over the same period.

We need to talk about sexuality after stroke
Stroke survivors and their partners are not adequately supported to deal with changes to their relationships, self-identity, gender roles and intimacy following stroke, according to new research from the University of Sydney.

Standardized stroke protocol can ensure ELVO stroke patients are treated within 60 minutes
A new study shows that developing a standardized stroke protocol of having neurointerventional teams meet suspected emergent large vessel occlusion (ELVO) stroke patients upon their arrival at the hospital achieves a median door-to-recanalization time of less than 60 minutes.

Read More: Stroke News and Stroke Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.